Thyroid cancer has become more common in recent years all around the world. Many issues
still need to be urgently addressed in the diagnosis, treatment, and prognosis of thyroid …

Background Thyroglobulin is a well-established disease marker during follow-up in
paediatric differentiated thyroid cancer. However, no conclusive data on the role of …

Objectives To explore the molecular mechanisms underlying aggressive progression of
papillary thyroid microcarcinoma and identify potential biomarkers. Methods Samples were …

Purpose To determine whether thyroid-stimulating hormone level≥ 30 mU/L is necessary
for radioiodine (131 I) remnant ablation (RRA) in patients with differentiated thyroid cancer …

BACKGROUND Thyroglobulin (Tg) is one of the markers of thyroid cancer, and its
concentration may be elevated in patients with malignant thyroid tumors. Thyroid-stimulating …

Background The incidence of thyroid cancer is on the rise worldwide, with childhood
exposure to radiation being the sole acknowledged catalyst for its emergence. Nonetheless …

Background Intraoperative neural monitoring (IONM) has been utilized for a variety of thyroid
pathologies, including papillary thyroid carcinoma (PTC). Remnant thyroid tissue following …

Matrix metalloproteinase 9 (MMP9) and microRNA-145 (miR-145) have emerged as
essential biomarkers in thyroid cancer progression and metastasis. However, their …

Purpose To explore the feasibility of individualized management of postoperative patients
with differentiated thyroid cancer by a mode based on internet and programming technology …

背景与目的: 淋巴结转移(lymph node metastasis, LNM) 是分化型甲状腺癌(differentiated
thyroid carcinoma, DTC) 最常见的转移, 而131 I 对LNM 的疗效存在争议, 本研究旨在明确131 I …